Related Experiment Video
Updated: Jun 6, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Advances and trends in dermato-oncology
Clio Dessinioti1, Helen Gogas, Alexander J Stratigos
1Department of Dermatology, University of Athens, Andreas Sygros Hospital, 5 I.Dragoumi Str, 16 121, Kaisariani, Athens, Greece.
The 6th European Association of Dermato-Oncology Congress highlighted advances in melanoma and skin cancer care. Personalized medicine is transforming risk prediction, prevention, and targeted treatments for skin malignancies.
Area of Science:
- Dermato-Oncology
- Malignant Skin Tumors
- Personalized Medicine
Background:
- The 6th Congress of the European Association of Dermato-Oncology convened in Athens, Greece, from June 16-19, 2010.
- The congress centered on recent breakthroughs in melanoma, epithelial skin cancers, and other malignant skin tumors.
Framework:
- The overarching theme was 'transforming care through personalized medicine'.
- The scientific program critically examined evolving aspects of skin cancer management, encompassing risk prediction, prevention strategies, and the application of targeted therapies.
Implementation:
- Key messages from selected presentations were highlighted.
- Discussions focused on the significant progress in understanding the pathogenesis of skin malignancies.
Implications:
- The rapid translation of scientific knowledge into effective clinical practice was emphasized.
- Advancements signify a new era in the management of skin cancer through personalized approaches.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

